| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1038119069 |
| P356 | DOI | 10.1186/S13014-016-0647-1 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/s13014-016-0647-1 |
| P932 | PMC publication ID | 4888512 |
| P698 | PubMed publication ID | 27251632 |
| P50 | author | Johann Matschke | Q89057705 |
| P2093 | author name string | Verena Jendrossek | |
| Sebastian Hurst | |||
| Justine Rudner | |||
| Elisa Wiebeck | |||
| P2860 | cites work | Significance of SGK1 in the regulation of neuronal function | Q24317440 |
| Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2 | Q24531452 | ||
| 'Desperate house genes': the dramatic example of hypoxia | Q24616815 | ||
| Regulation of ion channels by the serum- and glucocorticoid-inducible kinase SGK1 | Q26821941 | ||
| Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids | Q26996516 | ||
| Imaging tumor hypoxia to advance radiation oncology | Q27007862 | ||
| A new mathematical model for relative quantification in real-time RT-PCR | Q27860781 | ||
| Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects | Q28200181 | ||
| Exploiting tumour hypoxia in cancer treatment | Q28264146 | ||
| SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids | Q28481634 | ||
| Hypoxia--a key regulatory factor in tumour growth | Q29547318 | ||
| Targeting hypoxia in cancer therapy | Q29615491 | ||
| A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry | Q29617253 | ||
| Designing a broad-spectrum integrative approach for cancer prevention and treatment. | Q30736359 | ||
| Dynamics of hypoxia, proliferation and apoptosis after irradiation in a murine tumor model | Q33234509 | ||
| Targeting SGK1 in diabetes | Q33560146 | ||
| Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells | Q33627602 | ||
| Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment | Q33955139 | ||
| Molecular radiobiology: the state of the art | Q34124274 | ||
| Expression of the serum- and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells | Q34165571 | ||
| Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response | Q34375447 | ||
| Glucocorticoid adrenal steroids and glucocorticoid-inducible kinase isoforms in the regulation of GluR6 expression | Q34404007 | ||
| (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms | Q34570818 | ||
| Clonogenic assay of cells in vitro. | Q34615431 | ||
| Imaging cycling tumor hypoxia. | Q34686519 | ||
| Triglyceride accumulation protects against fatty acid-induced lipotoxicity | Q34866329 | ||
| Biochemical and physiological function of stearoyl-CoA desaturase | Q34898764 | ||
| Cycling hypoxia induces a specific amplified inflammatory phenotype in endothelial cells and enhances tumor-promoting inflammation in vivo | Q35024044 | ||
| NDRG2 phosphorylation provides negative feedback for SGK1-dependent regulation of a kainate receptor in astrocytes | Q36123449 | ||
| Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy | Q36545796 | ||
| Exposure to ionizing radiation induced persistent gene expression changes in mouse mammary gland | Q36552489 | ||
| Free fatty acid palmitate activates unfolded protein response pathway and promotes apoptosis in meniscus cells | Q36818380 | ||
| Detection and characterization of tumor hypoxia using pO2 histography | Q36834948 | ||
| Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids | Q36895786 | ||
| Lipid metabolism in cancer | Q38012542 | ||
| Tumor hypoxia as a driving force in genetic instability. | Q38155002 | ||
| Regulation of transport across cell membranes by the serum- and glucocorticoid-inducible kinase SGK1. | Q38177872 | ||
| Regulation of the epithelial Na+ channel by the mTORC2/SGK1 pathway. | Q38545109 | ||
| The role of lipid droplet formation in the protection of unsaturated fatty acids against palmitic acid induced lipotoxicity to rat insulin-producing cells | Q38624425 | ||
| Targeting fatty acid metabolism in cancer and endothelial cells | Q38630647 | ||
| Lipid desaturation - the next step in targeting lipogenesis in cancer? | Q38735369 | ||
| Targeted Inhibition of Glutamine-Dependent Glutathione Metabolism Overcomes Death Resistance Induced by Chronic Cycling Hypoxia. | Q38782792 | ||
| Genistein downregulates de novo lipid synthesis and impairs cell proliferation in human lung cancer cells | Q39544108 | ||
| Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells. | Q39561471 | ||
| Characterization of the serum metabolome following radiation treatment in patients with high-grade gliomas | Q39817583 | ||
| Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis. | Q39936514 | ||
| Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic. | Q39939547 | ||
| SGK1 kinase upregulates GLUT1 activity and plasma membrane expression | Q40323679 | ||
| Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer: the HIL trial | Q41686423 | ||
| Select ionotropic glutamate AMPA/kainate receptors are expressed at the astrocyte-vessel interface | Q44830012 | ||
| Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme | Q48181079 | ||
| Cerebral localization and regulation of the cell volume-sensitive serum- and glucocorticoid-dependent kinase SGK1. | Q48653353 | ||
| Biology of hypoxia. | Q51656540 | ||
| Impaired fatty acid oxidation as a cause for lipotoxicity in cardiomyocytes. | Q53657553 | ||
| Crystal Violet Assay for Determining Viability of Cultured Cells. | Q54340969 | ||
| Ypk1, the yeast orthologue of the human serum- and glucocorticoid-induced kinase, is required for efficient uptake of fatty acids. | Q54671084 | ||
| Expression of cell volume-regulated kinase h-sgk in pancreatic tissue | Q73127395 | ||
| Inhibition of colonic tumor growth by the selective SGK inhibitor EMD638683 | Q86068038 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | fatty acid | Q61476 |
| P304 | page(s) | 75 | |
| P577 | publication date | 2016-06-01 | |
| P1433 | published in | Radiation Oncology | Q2313370 |
| P1476 | title | Role of SGK1 for fatty acid uptake, cell survival and radioresistance of NCI-H460 lung cancer cells exposed to acute or chronic cycling severe hypoxia | |
| P478 | volume | 11 |
| Q47891451 | Cytoplasmic translocation of MTA1 coregulator promotes de-repression of SGK1 transcription in hypoxic cancer cells |
| Q61804436 | Oxidative stress: the lowest common denominator of multiple diseases |
| Q64102265 | Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors |
| Q91814537 | Targeting mTOR and Metabolism in Cancer: Lessons and Innovations |
| Q54978893 | The Mitochondrial Citrate Carrier (SLC25A1) Sustains Redox Homeostasis and Mitochondrial Metabolism Supporting Radioresistance of Cancer Cells With Tolerance to Cycling Severe Hypoxia. |
| Q98164823 | The prospect of serum and glucocorticoid-inducible kinase 1 (SGK1) in cancer therapy: a rising star |
Search more.